Competitive Research Brief · Interview Prep

Pivotal Health

Prepared for Kevin Lou · Screener for Product Manager, Financial Systems · May 20, 2026

30-second orientation

Pivotal Health (formerly Radix Health, rebranded Jan 2026) is a venture-backed health-tech company that helps healthcare providers recover fair reimbursement on out-of-network claims through the federal Independent Dispute Resolution (IDR) process created by the No Surprises Act. Think "software + service that wins arbitration cases for hospitals and physician groups." The role you're interviewing for owns the financial systems that track and report those recovered dollars back to customers.

The Company

Identity

Pivotal Health — pivotalhealth.ai. Rebranded from Radix Health on Jan 20, 2026 after a "monumental 2025." New brand emphasizes transparency, simplicity, and AI-powered software for a complex reimbursement ecosystem.

Leadership & Backing

Max Mangum — CEO & Co-Founder. Backed by Bessemer Venture Partners (partner Sofia Guerra publicly championed the company). Based in Los Angeles, CA; remote-friendly.

Stage & Momentum

Early-stage, fast-scaling startup. 2025 results cited in the rebrand: 15× client growth and partnerships with 20+ major RCM providers. Actively hiring across product, engineering, and business operations.

Your Role

Product Manager, Financial Systems — $130K–$165K, LA / remote. Owns the systems that track, report, and communicate financial outcomes to customers. Sits at the intersection of product, finance, and engineering.

What They Sell

A full-service IDR platform — technology plus hands-on service — that manages out-of-network payment disputes end-to-end. It integrates with all major Revenue Cycle Management (RCM) platforms and runs in the background. Three core capabilities:

Customers: Emergency medicine, anesthesiology, radiology, surgery, air ambulance groups, plus hospitals & health systems — "providers of all sizes."

The pricing hook — important for your role

Pivotal positions itself as the only IDR partner paid after its clients are — a contingency / success-fee model. They claim 95% success rates for hospitals. This makes accurate, trusted financial reporting the literal basis of how the company gets paid — which is exactly why the Financial Systems PM role exists.

Who Actually Pays? Following the Money

Pivotal's paying customer is the healthcare provider — physician groups (emergency medicine, anesthesiology, radiology, surgery, air ambulance) and hospitals / health systems, from small practices to large PE-backed groups. Not the patient, and not the insurer.

How the money flows

  1. A provider treats an out-of-network patient → the insurer underpays the claim.
  2. Pivotal files an IDR dispute on the provider's behalf and (usually) wins a higher payment.
  3. The insurer pays the provider the recovered amount.
  4. Pivotal takes a success fee — a cut of what it recovered — from the provider, after the provider has been paid.

The patient is deliberately out of it

The end healthcare user pays only their normal in-network cost-sharing — the entire point of the No Surprises Act is to remove the patient from the provider-vs-insurer fight. That dispute now happens behind the scenes, and Pivotal plays for the provider's side.

Net effect: the provider is the customer, but on a contingency model — Pivotal earns only when it recovers dollars the provider wouldn't otherwise have collected, which makes it a low-friction sale. It also means Pivotal's revenue is a slice of recovered dollars — which is precisely why the Financial Systems role exists.

How It Works: Identification & the End-to-End Lifecycle

Finding the opportunities — integration, not manual flagging

Pivotal doesn't wait for providers to hand-pick cases. The provider sets up a simple 835/837 file feed (837 = the claim submitted; 835 = the remittance showing what the insurer actually paid or denied). Pivotal's eligibility engine continuously scans that feed, compares billed vs. paid, and automatically flags underpaid, IDR-eligible out-of-network claims — filtering out ineligible / risky ones. Setup takes ~2 weeks, no IT overhaul, then it runs in the background.

What Pivotal manages — "from open negotiation to final payment collection"

Pivotal runs the entire arc, not just arbitration. Four stages per flagged claim:

  1. Identification — eligibility engine surfaces the underpaid OON claim from the 835/837 feed.
  2. Open negotiation — Pivotal initiates and runs the mandatory 30-business-day negotiation directly with the payer. Many claims resolve here, before IDR.
  3. IDR filing — if negotiation fails, Pivotal files within the 4-business-day window, batches similar claims to cut fees, and builds the data-backed position statement for the arbitrator.
  4. Final payment collection — tracks the dispute through to recovered dollars landing with the provider.

Negotiation isn't eliminated — it's a required first step

The No Surprises Act sequences negotiation and arbitration: a 30-business-day open negotiation window must be exhausted before IDR can be initiated, and parties can keep negotiating right up until the arbitrator's final determination. (The separate "big manual deal" lever for large orgs — going fully in-network via a payer contract — sits outside the NSA/IDR process entirely.)

Why this matters for your role: because Pivotal touches a claim from negotiation through final collection, the financial systems you'd own must attribute outcomes accurately at every stage — recovered in negotiation vs. won at IDR vs. still pending — across batched, multi-payer claims. That stage-by-stage tracking is the product problem behind the title.

What "cutting fees" means — the two IDR fees

Every IDR dispute incurs two distinct fees (2025 figures):

FeeAmountWho pays
Administrative fee (to the government)$115 per party, per disputeBoth sides — non-refundable, win or lose. Pure cost of entry.
Certified IDR Entity (IDRE) fee (the arbitrator)Single: $200–$840 · Batched: $268–$1,173 · +$75–$250 per extra 25 line items beyond the 25thBoth deposit it; the losing party effectively pays — the winner's deposit is refunded.

Batching turns a fixed per-dispute cost into a near-fixed per-batch cost. Filing 100 similar claims separately = 100 × $115 admin ($11,500) + 100 individual IDRE fees. Batching them into one dispute = a single $115 admin fee + one batched IDRE fee. The per-dispute admin fee is the biggest, most direct saving.

Why "Intelligent Batching" is a real product, not a checkbox

Claims can only be batched when they meet federal (and state) rules — same provider and payer, same/related service codes, same 30-business-day window, same geographic region. Mis-batch and the entire dispute can be ruled ineligible (recall ~20% of disputes industry-wide are tossed). Pivotal's engine is doing a constrained optimization: maximize fee savings against compliance risk.

The Problem Space: IDR & the No Surprises Act

The No Surprises Act (effective 2022) protects patients from surprise out-of-network bills (ER visits, anesthesiologists, etc.). It removes the patient from the fight and instead sends provider–insurer payment disputes to Independent Dispute Resolution (IDR): a certified third-party arbitrator picks one side's "final offer" (baseball-style arbitration).

The catch: the law cut provider out-of-network reimbursements by ~40%, and the IDR process is administratively brutal — strict eligibility rules, tight deadlines, per-claim fees, state vs. federal variation. Most providers leave money on the table because filing well is hard. That gap is the entire business.

1.2M
new disputes filed in H1 2025 (2× H1 2024)
88%
of disputes decided in providers' favor
~430K
disputes still backlogged (mid-2025)
~20%
of filed disputes are actually ineligible

Providers initiate 99.9% of disputes and win the vast majority — but two-thirds of decisions blow past the 30-day deadline. A market that's huge, growing, provider-favorable, and operationally messy.

Competitive Landscape

The space splits into three groups. Pivotal competes most directly with the middlemen — third-party firms that file IDR on providers' behalf.

PlayerTypeNotes
HaloMDDirect rivalThe 800-lb gorilla. Founded 2022; grew from 1% of disputes initiated (2023) to 22% by Q2 2025 — now the largest single initiator. AI tools + aggressive arbitration tactics. Has drawn payer lawsuits (Elevance, BCBS-TX) and lobbying attacks — a sign of its scale.
Radiology PartnersSelf-filerPE-backed mega-group; ~28% of all 2023–24 disputes. Files its own. A customer Pivotal would love to win, not really a vendor rival.
TeamHealth / SCP HealthSelf-filersLarge PE-backed staffing groups (~15%+ of disputes) filing in-house. Same dynamic — potential customers or build-vs-buy competitors.
FHAS, IPRO, MaximusArbitratorsCertified IDR entities — the neutral judges, not on the provider side. Adjacent, not competitors. Maximus also helps CMS build the new centralized IDR Gateway.
Claritev (ex-MultiPlan), ZelisPayer-sideOut-of-network repricing — Claritev handles ~80% of OON repricing. They sit on the insurer side, the structural counter-party to Pivotal's customers.
Imagine Software, RCM platformsChannelBilling/RCM vendors adding IDR features. Pivotal's "integrate with 20+ RCM partners" strategy turns many of these into distribution channels rather than rivals.

Counterparty Research: The Other Side of the Table

When Pivotal sends an open negotiation notice or files an IDR case, who responds? Nominally the health plan / insurer — UnitedHealthcare, Aetna, Cigna, Elevance (Anthem), the BCBS plans, plus self-funded employer plans and their TPAs. In practice, insurers rarely use their own staff: they outsource negotiation and dispute defense to specialized out-of-network "cost-containment" vendors — the structural mirror image of Pivotal.

Payer-side vendorRole
Claritev (formerly MultiPlan)The giant — reprices ~80% of out-of-network claims nationally. Its algorithm sets the low payment that triggers the dispute in the first place.
ZelisMarkets an explicit payer-side NSA product — manages open negotiation and IDR responses for health plans: timely filing, settlement, QPA determinations, "compliant responses to provider disputes."
Data iSight, Naviguard, othersAdditional repricing / dispute-defense services. Naviguard is UnitedHealth's in-house arm.

It's vendor vs. vendor — software against software

Pivotal isn't negotiating with an individual at the insurer; it's facing another tech-plus-service platform (Zelis or similar) acting for the payer. Payer-side vendor's job: keep payouts low, defend the QPA. Pivotal's job: push payouts up. The arbitrator (IDRE — Maximus, FHAS, IPRO) is the neutral party who picks a winner. Better data and faster, more accurate systems win.

Tailwind: the payer-side vendors are under legal fire

An antitrust lawsuit against five major insurers (cleared federal court in early 2026) alleges their repricing algorithms — MultiPlan/Claritev and Zelis — colluded to systematically underpay providers. If courts curb aggressive payer-side repricing, providers have even more reason to dispute — a macro tailwind for Pivotal.

How Pivotal Stacks Up

Strengths

  • Success-fee model — low-friction sale, aligned incentives
  • RCM integrations as a distribution moat (20+ partners)
  • Data-driven position statements + eligibility filtering
  • Bessemer backing; 15× growth credibility

Weaknesses / Unknowns

  • Far smaller than HaloMD's docket share
  • Newer brand (rebrand may dilute Radix recognition)
  • Single-product dependence on one regulatory regime

Opportunities

  • Backlog + doubling dispute volume = expanding TAM
  • Hospitals & health systems = upmarket expansion
  • State-level IDR variation rewards a compliance engine
  • Adjacent underpayment / denials beyond IDR

Threats

  • Regulatory reform — experts are calling for NSA changes
  • Payer lawsuits targeting IDR "middlemen" (see HaloMD)
  • CMS's centralized IDR Gateway could commoditize filing
  • RCM partners building IDR in-house

Why This Matters for Your Role

Connect the dots in the interview

Because Pivotal is paid only when clients recover money, the "financial systems" you'd own are not back-office plumbing — they're the system of record for revenue, customer invoicing, and trust. Accurately attributing "we recovered $X for you" across thousands of batched, multi-payer, multi-state claims is genuinely hard. That's a meaty product problem at the product/finance/engineering seam — lean into it.

Smart Questions to Ask Them

How does the team think about defending against HaloMD's scale — is the wedge product depth, RCM distribution, or service quality?

What's the product roadmap risk if the No Surprises Act or IDR rules get reformed? How diversified is the revenue beyond federal IDR?

For the Financial Systems role specifically — what's broken or manual today in how you track and report recovered dollars to customers?

How does CMS's new centralized IDR Gateway change the platform strategy?

What does success look like for this role in the first 6–12 months, and who are the key cross-functional partners (finance, eng)?

Post-rebrand, what's the next chapter — staying focused on IDR, or expanding into the broader provider-underpayment space?